Author

Jessica Suh

Institutions: National Institutes of Health, National Center for Advancing Translational Sciences

Observed institutions: National Institutes of Health, The University of Texas MD Anderson Cancer Center, National Center for Advancing Translational Sciences

ORCID: 0009-0007-3758-8708

Observed ORCID: 0009-0007-3758-8708

OpenAlex ID: A5029826248

Beyond amyloid: nanobody-mediated neuroinflammatory therapy for Alzheimer’s disease

2025 · Soukaina Amniouel, Jessica Suh, et al. · Translational Neurodegeneration · 8

CHIP protects lysosomes from CLN4 mutant-induced membrane damage

2025 · Juhyung Lee, Natalie Chin, et al. · Nature Cell Biology · 7

An ALS-associated TARDBP mutation drives cryptic exon inclusion and RNA dysregulation

2025 · Qi Zhang, Meng Liu, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 5

KDM4A promotes NEPC progression through regulation of MYC expression

2025 · Celia Sze Ling Mak, Ming Zhu, et al. · Cancer Letters · 4

Abstract 1803: ACOD1 is a key regulator of immunosuppressive MDSCs, prostate cancer progression, and resistance to immunotherapy

2024 · Celia Sze Ling Mak, Xin Liang, et al. · Cancer Research

Abstract 4760: KDM4A promotes NEPC progression through regulation of MYC expression

2023 · Celia Sze Ling Mak, Ming Zhu, et al. · Cancer Research

KDM4A promotes the progression of neuroendocrine prostate cancer

2022 · Celia Sze Ling Mak, Ming Zhu, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Targeting histone lysine demethylase KDM4A in Aggressive Variant Prostate Cancer

2022 · Celia Sze Ling Mak, Ming Zhu, et al.

Works count: 8

Citation count: 24

H-index: 4

I10-index: